Nicotine Metabolism in African Americans and European Americans: Variation in Glucuronidation by Ethnicity and UGT2B10 Haplotype

• Published in: The Journal of pharmacology and experimental therapeutics 2010-01, Vol.332 (1), p.202-209
• Main Authors: Berg, Jeannette Zinggeler, Mason, Jesse, Boettcher, Angela J, Hatsukami, Dorothy K, Murphy, Sharon E
• Format: Article
• Language: English
• Subjects: Adult; African Americans - genetics; Cotinine - metabolism; Cotinine - urine; DNA - genetics; European Continental Ancestry Group - genetics; Female; Glucuronides - metabolism; Glucuronides - urine; Glucuronosyltransferase - genetics; Glucuronosyltransferase - physiology; Haplotypes; Humans; Male; Metabolism, Transport, and Pharmacogenomics; Microsomes, Liver - enzymology; Middle Aged; Nicotine - metabolism; Nicotine - urine; Smoking Cessation; Tobacco Use Disorder - enzymology; Tobacco Use Disorder - ethnology; Tobacco Use Disorder - metabolism
• ISSN: 0022-3565; 1521-0103
• DOI: 10.1124/jpet.109.159855

Nicotine is the major addictive agent in tobacco smoke, and it is metabolized extensively by oxidation and glucuronide conjugation. The contributions of ethnicity and UGT2B10 haplotype on variation in nicotine metabolism were investigated. Nicotine metabolism was evaluated in two populations of smokers. In one population of African American and European American smokers ( n = 93), nicotine and its metabolites were analyzed in plasma and 24-h urine over 3 days while participants were abstinent and at steady state on the nicotine patch. In a second study of smokers ( n = 84), the relationship of a UGT2B10 haplotype linked with D67Y to nicotine and cotinine glucuronidation levels was determined. We observed that both African American ethnicity and the UGT2B10 D67Y allele were associated with a low glucuronidation phenotype. African Americans excreted less nicotine and cotinine as their glucuronide conjugates compared with European Americans; percentage of nicotine glucuronidation, 18.1 versus 29.3 ( p < 0.002) and percentage of cotinine glucuronidation, 41.4 versus 61.7 ( p < 0.0001). In smokers with a UGT2B10 Tyr67 allele, glucuronide conjugation of nicotine and cotinine was decreased by 20% compared with smokers without this allele. Two key outcomes are reported here. First, the observation that African Americans have lower nicotine and cotinine glucuronidation was confirmed in a population of abstinent smokers on the nicotine patch. Second, we provide the first convincing evidence that UGT2B10 is a key catalyst of these glucuronidation pathways in vivo.